Related Experiment Video

Updated: Oct 8, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

[Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research]

Tadashi Watanabe1, Masahiro Fujimuro1

  • 1Department of Cell Biology, Kyoto Pharmaceutical University.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|January 5, 2019
PubMed

Insights

Kaposi's sarcoma-associated herpesvirus (KSHV) causes deadly cancers. Understanding KSHV

Area of Science:

  • Virology and Molecular Biology
  • Oncology
  • Infectious Diseases

Background:

  • Kaposi's sarcoma-associated herpesvirus (KSHV) is linked to Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and Castleman's disease.
  • Current treatments for KSHV-associated malignancies have limited efficacy, with low survival rates for PEL patients.
  • Developing novel anti-KSHV drugs targeting viral replication is crucial due to lifelong KSHV infections and delayed drug development.

Purpose of the Study:

  • To elucidate the KSHV life cycle and replication machinery for novel therapeutic strategies.
  • To identify potential drug targets by understanding the molecular mechanisms of KSHV.
  • To screen for anti-PEL compounds and analyze KSHV coding genes using recombinant KSHV.

Main Methods:

  • Screening for anti-PEL compounds using PEL-derived cell lines.
  • Utilizing recombinant KSHV for functional analysis of KSHV coding genes.
  • Investigating the viral pre-initiation complex and its molecular mechanism, focusing on KSHV ORF34.

Main Results:

  • Identified a viral pre-initiation complex conserved among beta- and gammaherpesviruses, essential for viral protein expression.
  • Demonstrated that KSHV ORF34 contributes to viral late gene expression through the formation of this complex.
  • Established functional homology between the viral pre-initiation complex and host cell pre-initiation complexes.

Conclusions:

  • Elucidating KSHV's molecular mechanisms, particularly the viral pre-initiation complex, is key to developing effective anti-KSHV therapies.
  • KSHV ORF34 plays a critical role in viral replication by facilitating late gene expression.
  • Further research into the KSHV life cycle and replication machinery can lead to improved treatments for KSHV-associated diseases.
Keywords:
Kaposi's sarcomaKaposi's sarcoma-associated herpesvirusherpesvirusprimary effusion lymphomaviral pre-initiation complex

More Related Videos

Quantitative Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF) of Specific Gene Products in KSHV-Infected Cells00:06

Quantitative Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF) of Specific Gene Products in KSHV-Infected Cells

Published on: August 27, 2019

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...